Stay updated on Clinical Trial: Higher Dose BGB324 in Lung Cancer
Sign up to get notified when there's something new on the Clinical Trial: Higher Dose BGB324 in Lung Cancer page.

Latest updates to the Clinical Trial: Higher Dose BGB324 in Lung Cancer page
- ChecktodayChange DetectedA site-wide notice says NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check7 days agoChange DetectedThe site footer’s revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the expected study details and navigation, indicating an access problem that prevents viewing the trial information.SummaryDifference18%

- Check56 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, signaling a minor page/template update rather than a change to trial details or functionality.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page's revision tag updated from v3.6.4 to v3.6.5, signaling a small platform update with no evident changes to the study content.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Higher Dose BGB324 in Lung Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Higher Dose BGB324 in Lung Cancer page.